Molecular, Cellular, & Tissue Engineering
Cellulases are of considerable current interest for converting the cellulosic content of biomass to fermentable sugars for biofuels production.
For the past two decades the capability of protein engineers to devise clever tumor-targeting molecules has outstripped our understanding of how these agents distribute through the body and permeate through tumors.
Stem cells have become a promising cell source in the tissue engineering field.
Worth over $30 billion, therapeutic proteins, produced by recombinant mammalian cells, have been the fastest growing class of medicines in industrialized nations.
Modern recombinant DNA expression technologies, by definition, challenge cells to engage in unnatural acts; specifically, the production of new types and large quantities of proteins for which the cells have not evolved.
The drug discovery process is expensive and often inefficient. With the emergence of genomic and proteomic information, the growth of critical molecular targets is rapid.
Stem cells are defined by their capacities for self-renewal and differentiation into one or more cell lineages, and these processes are regulated by signals from the stem cell microenvironment, or niche, in various tissues throughout organismal de
Bacterial quorum sensing offers an interesting viewpoint from which to study and control cell phenotype.